medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2003, Number 3

<< Back Next >>

Rev Mex Oftalmol 2003; 77 (3)

Presente y futuro de las infecciones por Chlamydia trachomatis. Análisis de las perspectivas de la Organización Mundial de la Salud y su importancia para México

González-Almaraz G, Pineda-Cárdenas MAA

Language: Spanish
References: 49
Page: 110-119
PDF size: 763.86 Kb.


ABSTRACT

Chlamydial infections are becoming to be the most important cause of blindness at the whole world, and prevention is suitable by hygienic and medical procedures. Surgical methods should be avoided at the present and disappear at the future. The standardisation in the diagnoses and therapy should be adequately established. The WHO recently proposed a general protocol under the term "SAFE". The objective of this paper is only the diffusion of such protocol and the comparison of our experience in the last years.


REFERENCES

  1. González-Almaraz, G.: Infecciones por Chlamydia trachomatis. Ed. Arenas, México, 1993, pp.103-105.

  2. Lietman, T.; Brooks, D.; Moncada, J.; Schachter, J.; Dawson, C.; Dean, D.: Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniae. Clin Infect Dis, 1998; 26(6):1335-1340.

  3. Girjes, A.A.; Carrick, F.N.; Lavin, M.F.: Remarkable sequence relatedness in the DNA encoding the major membrane protein of Chlamydia psittaci (koala type I) and Chlamydia pneumoniae. Gene, 1994; 138(1-2):139-142.

  4. Gaydos, C.A.; Palmer, L.; Quinn, T.C.; Falkows, S.; Eiden, J.J.: Phylogenetic relationship of Chlamydia pneumoniae to Chlamydia psitacci and Chlamydia trachomatis as determined by analysis of 16S ribosomal DNA sequences. Int J Syst Bacteriol, 1993; 43(839):610-612.

  5. Ludany, S.; Sarow, I.: Recent advances in Chlamydia trachomatis. Eur J Epidemiol; 1985; 1(49):235-256.

  6. Bachmaier, K.; Neu, N.; De la Maza, L.M.; Sukumar, P.; Hessel; Penninger, J.M.: Chlamydia infections and heart disease linked through antigenic mimicry. Science, 1999, 283(26):1335-1339.

  7. Thylefors, B. y col.: La surveillance épidémiologique du trachome: bilan et perspective. Rev Intern Trachome, 1992; 69:107-114.

  8. González-Almaraz, G.; Pineda-Cárdenas, Ma.A.A.; Garza-Ruiz, E.: Chlamydia trachomatis como causa de infección ocular en las conjuntivitis foliculares. Bol Hosp Oft Nta Sra de la Luz, 2001; 70(193):85-90.

  9. Riva, C.; Perlino, P.; Valpreda, A.; Ricotti, E.; Castagneri, G.; Balbo, L.; Musso, A.: Long lasting conjunctivitis. Research of etiological factors. Minerva Pediatr, 1992, 44(12): 595-600.

  10. Adenis, J.P.; Saint-Blancat, P.; Ranger, S.; Martin, P.; Duprat, F.; Barbarie, S.: Chlamydia trachomatis conjunctivites in adults. Study of diagnostic techniques. J Fr Ophtalmol, 1993; 16(3):178-83.

  11. Ludany, S.; Sarow, I.: Recent advances in Chlamydia trachomatis. Eur J Epidemiol, 1985; 1(49):235-256.

  12. Lietman, T.; Brooks, D.; Moncada, J.; Schachter, J.; Dawson, C.; Dean, D.: Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniae. Clin Infect Dis, 1998; 26(6):1335-1340.

  13. Pérez-Meigosa, M.; Kuo, C.C.; Campbell, L.A.: Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kilodalton protein containing a species specific epitope. Infect Immun, 1994; 62(3):880-886.

  14. Woodland, R.M.; Darougar, S.; Thaker, U.; Cornell, L.; Siddique, M.; Wania, J.; Sha, M.: Causes of conjunctivities and keratoconjunctivities in Karachi, Pakistan. Trans R Soc Trop Med Hyg, 1992, 86(3):317-320.

  15. González-Almaraz, G.; Pineda-Cárdenas, Ma.A.A.: La Chlamydia trachomatis como causa de rinitis. An ORL Mex, 1998; 43(1):21-25.

  16. González-Almaraz, G.; Herrera-Jiménez, A.; Pineda-Cárdenas, Ma.A.A.: Complicaciones nasofaríngeas de la conjuntivitis folicular por Chlamydia trachomatis. Una causa de la falta de respuesta al tratamiento. Rev Mex Oftalmol, 1997; 71(4):133-138.

  17. González-Almaraz, G.; Pineda-Cárdenas, Ma.A.A.: Diagnóstico diferencial de la queratoconjuntivitis folicular. Rev Mex Oftalmol, 1987; 61(59):233-237.

  18. González-Almaraz, G.; Pineda-Cárdenas, Ma.A.A.: La eritromicina en el tratamiento local de las infecciones por Chlamydia trachomatis. Rev Mex Oftalmol, 1994; 68(6):211-216.

  19. González-Almaraz, G.; Pineda-Cárdenas, Ma.A.A.: Conjuntivitis por adenovirus. (Estudio retrospectivo de un posible brote epidémico en México). Rev Mex Oftalmol, 1991; 65:65-73.

  20. González-Almaraz, G.; Pineda-Cárdenas, Ma.A.A.: Diagnóstico citológico de la conjuntivitis por Chlamydia trachomatis. Rev Mex Oftalmol, 1987; 61(4):179-184.

  21. González-Almaraz, G.; Pineda-Cárdenas, Ma.A.A.: La Citología exfoliativa en la oftalmología. An Soc Mex Oftalmol, 1986; 60(29):61-67.

  22. Jones, B.R.: Laboratory tests for Chlamydial infection: Their role in epidemiological studies of trachoma and its control. Brit J Ophthal, 1974; 58(4):438-454.

  23. Wilhelmus, R.K.; Robinson, N.M.; Tredici, L.L.; Jones, D.B.: Conjuntctival cytology of adult Chlamydia conjunctivitis. Arch Opthalmol, 1986; 104:691-693.

  24. Yoneda, C.; Dawson, C.R.; Daghfous, T.; Hoshiwara, I.; Jones, P.; Messadi, M.; Schachter, J.: Cytology as a guide to the presence of Chlamydial inclusions in Giemsa-stained conjunctival smears in severe endemic trachoma. Brit J Ophthalmol, 1975; 59(3): 116-124.

  25. Janssen, K.; Gerding, H.; Busse, H.: Recurrent canaliculitis and dacryocystitis as a sequela of persistent infection with Chlamydia trachomatis. Ophthallmologe, 1933; 90(1): 17-20.

  26. Riva, C.; Perlino, P.; Valpreda, A.; Ricotti, E.; Castagneri, G.; Balbo, L.; Musso, A.: Long lasting conjunctivitis. Research of etiological factors. Minerva Pediatr, 1992; 44(12): 595-600.

  27. Talley, A.R.; García-Ferrer, F.; Laycock, K.A.; Loeffelholz, M.; Pepose, J.S.: The use of polymerase chain reaction for the detection of Chlamydial keratoconjunctivis. Am J Ophthalmol, 1992; 114(6):685- 692.

  28. WHO: Planning for the Global Elimination of Trachoma (GET). Report of a Global Scientific Meeting. pbl/96.56.

  29. Bailey, R.L.; Arullendran, P.; Whittle, H.C. y col.: Randomized controlled trial of a single dose of azithromycin in treatment of trachoma. Lancet, 1993; 342:453-456.

  30. Dawson, C.R.; Schachters, J.; Sallan, S. y col.: A comparison of oral Azithromycin with topical Oxytetracycline/ Polymyxin for the treatment of trachoma in children. Clin Infect Dis, 1997; 24:363-368.

  31. Tabarra, K.F.; Abu El-Asrar, A.M.; Al-Omar, O. Y col.: Singledose Azithromycin in the treatment of trachoma. A randomized controlled study. Ophthalmology, 1996; 103: 842-846.

  32. Langtry, H.D.; Balfour, J.A.: Azithromycin. A review of its use in paediatric infectious diseases. Drugs, 1998; 2:273-297.

  33. Bailey, R.; Osmond, C.; Mabey, D.C. y col.: Analysis of the household distribution of trachoma in a Gambian village using a Monte Carlo simulation procedure. Int J Epidemiol, 1989; 18:944-951.

  34. Sahlo, T.; Larson, C.: The prevalence of environmental risk factors for moderate and severe trachoma in southern Ethiopia. J Trop Med Hyg, 1992; 95:36-41.

  35. Assaad, F.A.; Maxwell-Lyons, F.; Sundaresan, T.: Use of local variations in trachoma endemicity in depicting interplay between socio-economic conditions and disease. Bull World Health Org, 1969; 41:181-194.

  36. West, S.K.; Munoz, B.; Turner, V.M. y col.: The epidemiology of trachoma in central Tanzania. Int J Epidemiol, 1991; 20:1088-1092.

  37. Katz, J.; Zeger, S.L.; Tielsch, J.M.: Village and the household clustering of xerophthalmia and trachoma. Int J Epidemiol, 1988; 17:865-869.

  38. Munoz, B.; West, S.; Taylor, H.R.: The dynamics of intrafamily transmission of trachoma. Invest Ophthalmol Vis Sci, 1989; 30(suppl):438.

  39. Congdon, N.; West, S.; Vitale, S. y col.: Exposure to children and risk of active trachoma in Tanzanian women. Am J Epidemiol, 1993;137:366-372.

  40. Taylor, H.R.: Towards the global elimination of trachoma. Nat Med, 1999; 5:492-493.

  41. Berdal, B.P.; Scheel, O.: Chlamydia pneumoniae-pathogenesis and pespectives. Tidsskr Nor Laegeforen, 1993; 113(7):859-861.

  42. Toney, J.F.; Larkin, J.: Contemporary strategies for detecting Chlamydial infection in women. Medscope Womens Health, 1996; 1(15):1.

  43. Ludany, S.; Sarow, I.: Recent advances in Chlamydia trachomatis. Eur J Epidemiol, 1985; 1(49):235-256.

  44. Lisby, S.M.; Nahata, M.C.: Recognition and treatment of Chlamydial infections. Clin Pharm, 1987, 6(19):25-36.

  45. Robinson, A.J.; Ridgway, G.L.: Modern diagnosis and management of genital Chlamydia trachomatis infection. Br J Hosp Med, 1996; 55(7):388-393.

  46. González-Almaraz, G.: Diagnóstico citopatológico de las queratitis herpéticas por medio del raspado corneal. An Soc Mex Oftal, 1979: 53:93-102.

  47. González-Almaraz, G.; Pineda-Cárdenas, Ma.A.A.; Rabinovitz, K.E.; Limón, E.: Etiología de las queratoconjuntivitis (estudio comparativo entre una población socieconómica débil y otra de altos ingresos). Rev Mex Oftalmol, 1987; 61(3):125-130.

  48. Queratitis herpética. Correlación clínico-patológica de 101 casos. An Soc Mex Oftal, 1978; 52:159-172. Publicado por petición editorial en: Rev Oftalmológica (Lima), 1(2):66-72; 1978.

  49. De Buen, S.; González-Almaraz, G.: Queratomicosis: Importancia del raspado corneal para su diagnóstico y tratamiento. Gac Med Mex, 1977; 113(5):239-244.




2020     |     www.medigraphic.com